ZEMAX renewal of DBP licenses.

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$10,000 to $25,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
511210 Software Publishers
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration (FDA) is forecasting a renewal of ZEMAX DBP licenses, categorized under Software Publishers (NAICS 511210). The solicitation is estimated to be released on April 1, 2026, with an anticipated contract award date of June 1, 2026. This new requirement appears to focus on software license renewal for the agency's operational needs.

While specific award value details are not provided, the opportunity involves renewing existing software licenses with potential strategic importance to FDA operations. The point of contact for this opportunity is Joshua Holliday, who can be reached at joshua.holliday@fda.hhs.gov within the FDA organization. Given the federal government procurement process, interested vendors should carefully review the forthcoming solicitation details and ensure they meet the necessary qualifications for software licensing.

Forecast text

ZEMAX renewal of DBP licenses.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast